Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/183062
Title: | MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice |
Author: | Santos García, Diego Álvarez Sauco, Maria Calopa, Matilde Carrillo, Fátima Escamilla Sevilla, Francisco Freire, Eric García Ramos, R. Kulisevsky, Jaime Gómez Esteban, Juan Carlos Legarda, Inés Luquín, María Rosario Isabel Castrillo, Juan Carlos Martínez Martínez Martin, Pablo Martínez Torres, Irene Mir, Pablo Ignacio, Ángel Sesar |
Keywords: | Malaltia de Parkinson Manifestacions neurològiques de les malalties Parkinson's disease Neurologic manifestations of general diseases |
Issue Date: | 28-Dec-2021 |
Publisher: | MDPI AG |
Abstract: | Background and objective: Parkinson's disease (PD) is a clinically heterogeneous disorder in which the symptoms and prognosis can be very different among patients. We propose a new simple classification to identify key symptoms and staging in PD. Patients and Methods: Sixteen movement disorders specialists from Spain participated in this project. The classification was consensually approved after a discussion and review process from June to October 2021. The TNM classification and the National Institutes of Health Stroke Scale (NIHSS) were considered as models in the design. Results: The classification was named MNCD and included 4 major axes: (1) motor symptoms; (2) non-motor symptoms; (3) cognition; (4) dependency for activities of daily living (ADL). Motor axis included 4 sub-axes: (1) motor fluctuations; (2) dyskinesia; (3) axial symptoms; (4) tremor. Four other sub-axes were included in the non-motor axis: (1) neuropsychiatric symptoms; (2) autonomic dysfunction; (3) sleep disturbances and fatigue; (4) pain and sensory disorders. According to the MNCD, 5 stages were considered, from stage 1 (no disabling motor or non-motor symptoms with normal cognition and independency for ADL) to 5 (dementia and dependency for basic ADL). Conclusions: A new simple classification of PD is proposed. The MNCD classification includes 4 major axes and 5 stages to identify key symptoms and monitor the evolution of the disease in patients with PD. It is necessary to apply this proof of concept in a properly designed study. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/diagnostics12010055 |
It is part of: | Diagnostics, 2021, vol 12, num 1 |
URI: | https://hdl.handle.net/2445/183062 |
Related resource: | https://doi.org/10.3390/diagnostics12010055 |
ISSN: | 2075-4418 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
diagnostics-12-00055.pdf | 3.03 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License